In the last trading session, 19.38 million shares of the Hologic, Inc (NASDAQ:HOLX) were traded, and its beta was 0.52. Most recently the company’s share price was $62.17, and it changed around $7.89 or 14.54% from the last close, which brings the market valuation of the company to $13.85B. HOLX currently trades at a discount to its 52-week high of $84.67, offering almost -36.19% off that amount. The share price’s 52-week low was $51.90, which indicates that the current value has risen by an impressive 16.52% since then. We note from Hologic, Inc’s average daily trading volume that its 10-day average is 4.25 million shares, with the 3-month average coming to 3.13 million.
Hologic, Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.50. If we narrow it down even further, the data shows that 0 out of 21 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 14 recommended HOLX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Hologic, Inc is expected to report earnings per share of 1.05 for the current quarter.
Hologic, Inc (NASDAQ:HOLX) trade information
Instantly HOLX has showed a green trend with a performance of 14.54% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 68.25 on recent trading dayincreased the stock’s daily price by 8.91%. The company’s shares are currently down -13.76% year-to-date, but still up 10.17% over the last five days. On the other hand, Hologic, Inc (NASDAQ:HOLX) is 7.15% up in the 30-day period. We can see from the shorts that 5.35 million shares have been sold at a short interest cover period of 1.59 day(s).
The consensus price target as assigned by Wall Street analysts is $65, which translates to bulls needing to increase their stock price by 4.35% from its current value. Analyst projections state that HOLX is forecast to be at a low of $65 and a high of $65.
Hologic, Inc (HOLX) estimates and forecasts
The year-over-year growth rate is expected to be 1.12%, up from the previous year.
Consensus estimates provided by 15 financial analysts predict the company will bring in an average of 1.01B in revenue for the current quarter. 15 analysts expect Hologic, Inc to make 1.03B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 1.01B and 987.9M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -0.54%. Forecasts for the next quarter put sales growth at 4.68%.
Hologic, Inc earnings are expected to increase by 2.55% in 2025, but the outlook is positive 6.89% per year for the next five years.
HOLX Dividends
Hologic, Inc’s next quarterly earnings report is expected to be released on 2025-Apr-30.
Hologic, Inc (NASDAQ:HOLX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.86% of Hologic, Inc shares, and 102.75% of them are in the hands of institutional investors. The stock currently has a share float of 103.64%. Hologic, Inc stock is held by 1100.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 11.4121% of the shares, which is about 26.77 million shares worth $1.99 billion.
BLACKROCK INC., with 9.8459% or 23.1 million shares worth $1.72 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
T. Rowe Price Mid-Cap Growth Fund, Inc. and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 8.5 shares worth $528.44 million, making up 3.81% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 7.1 shares worth around $441.11 million, which represents about 3.18% of the total shares outstanding.
